• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用埃尔曼法测定人体血液胆碱酯酶活性的方案比较

Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method.

作者信息

Reiner E, Sinko G, Skrinjarić-Spoljar M, Simeon-Rudolf V

机构信息

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

出版信息

Arh Hig Rada Toksikol. 2000 Mar;51(1):13-8.

PMID:11059068
Abstract

This paper presents a protocol for routine assays of human blood cholinesterase activities which separates erythrocytes from plasma by centrifugation and measures acetylcholinesterase activity in unwashed erythrocytes and butyrylcholinesterase activity in the plasma. The recommended substrate for both enzymes is 1.0 mM acetylthiocholine. The protocol is compared with other two recommended protocols for the activity measurements of the two enzymes using the Ellman method. The paper discusses the advantages and disadvantages of each and concludes with a proposal for an international agreement between laboratories for the evaluation of a standardized protocol.

摘要

本文介绍了一种用于人体血液胆碱酯酶活性常规检测的方案,该方案通过离心将红细胞与血浆分离,并测定未洗涤红细胞中的乙酰胆碱酯酶活性以及血浆中的丁酰胆碱酯酶活性。两种酶推荐使用的底物均为1.0 mM乙酰硫代胆碱。该方案与另外两种使用埃尔曼方法测定这两种酶活性的推荐方案进行了比较。本文讨论了每种方案的优缺点,并最后提议实验室之间达成一项国际协议,以评估标准化方案。

相似文献

1
Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method.采用埃尔曼法测定人体血液胆碱酯酶活性的方案比较
Arh Hig Rada Toksikol. 2000 Mar;51(1):13-8.
2
Activity of cholinesterases in human whole blood measured with acetylthiocholine as substrate and ethopropazine as selective inhibitor of plasma butyrylcholinesterase.
Arh Hig Rada Toksikol. 2004 Apr;55(1):1-4.
3
A new approach to determining cholinesterase activities in samples of whole blood.一种测定全血样本中胆碱酯酶活性的新方法。
Clin Chim Acta. 1978 Oct 16;89(2):239-52. doi: 10.1016/0009-8981(78)90322-4.
4
Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.将未稀释血浆和红细胞中的胆碱酯酶活性(EC 3.1.1.7;3.1.1.8)作为测量可逆性抑制剂体内效应的一种工具进行评估。
J Clin Chem Clin Biochem. 1988 Jul;26(7):469-75. doi: 10.1515/cclm.1988.26.7.469.
5
Comparative kinetic analysis of cholinesterase methods in rat and human erythrocytes and plasma.大鼠和人红细胞及血浆中胆碱酯酶检测方法的比较动力学分析
Vet Hum Toxicol. 1997 Feb;39(1):11-7.
6
Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.美国陆军传染病医学研究所全血胆碱酯酶检测法的优势:与微量埃尔曼法、Test-mate胆碱酯酶检测法和米歇尔(ΔpH)检测法的对比分析
Chem Biol Interact. 2008 Sep 25;175(1-3):417-20. doi: 10.1016/j.cbi.2008.04.032. Epub 2008 May 3.
7
Cholinesterase activities in blood in infantile autism.
Biol Psychiatry. 1987 Feb;22(2):234-6. doi: 10.1016/0006-3223(87)90238-1.
8
Measurement of erythrocyte acetylcholinesterase and plasma cholinesterase activity by a differential pH technique.采用差分pH技术测定红细胞乙酰胆碱酯酶和血浆胆碱酯酶活性。
Ann Clin Biochem. 1986 Sep;23 ( Pt 5):538-45. doi: 10.1177/000456328602300509.
9
Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.阿尔茨海默病患者脑脊液、血浆和红细胞中的胆碱酯酶。
J Neural Transm. 1989;75(2):119-27. doi: 10.1007/BF01677425.
10
[Cholinesterase hydrolysis of specific substrates at different concentrations].[不同浓度下特定底物的胆碱酯酶水解作用]
Dokl Akad Nauk SSSR. 1981;258(5):1233-5.

引用本文的文献

1
Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin.评估杀菌剂甲呋氟菌腈和吡唑醚菌酯的抗胆碱酯酶活性。
Int J Mol Sci. 2024 Jun 7;25(12):6310. doi: 10.3390/ijms25126310.
2
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability.新型奎宁环衍生化合物作为潜在抗胆碱酯酶药物的分析:酶抑制作用及其对细胞活力的影响。
Int J Mol Sci. 2023 Dec 21;25(1):155. doi: 10.3390/ijms25010155.
3
Evaluation of the Key Structural Features of Various Butyrylcholinesterase Inhibitors Using Simple Molecular Descriptors.
利用简单分子描述符评价各种丁酰胆碱酯酶抑制剂的关键结构特征。
Molecules. 2022 Oct 14;27(20):6894. doi: 10.3390/molecules27206894.
4
Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase.利用连接性指数和简单拓扑参数估算乙酰胆碱酯酶的抑制效力。
Saudi Pharm J. 2022 Apr;30(4):369-376. doi: 10.1016/j.jsps.2022.01.025. Epub 2022 Feb 8.
5
Three-dimensional brain-on-chip model using human iPSC-derived GABAergic neurons and astrocytes: Butyrylcholinesterase post-treatment for acute malathion exposure.利用人诱导多能干细胞衍生的 GABA 能神经元和星形胶质细胞的三维脑芯片模型:经丁酰胆碱酯酶处理后急性马拉硫磷暴露。
PLoS One. 2020 Mar 12;15(3):e0230335. doi: 10.1371/journal.pone.0230335. eCollection 2020.
6
New therapeutic approaches and novel alternatives for organophosphate toxicity.新型治疗方法和有机磷毒性的新替代物。
Toxicol Lett. 2018 Jul;291:1-10. doi: 10.1016/j.toxlet.2018.03.028. Epub 2018 Mar 31.